Objective: The aim of the study was to determine the clinical characteristics, comorbidities, responsible diseases and in-hospital mortality of patients who received a temporary pacemaker
Methods: Our study included 545 patients who received a temporary pacemaker due to various causes during their hospitalization between January 2008 and May 2012.
Results: Of the 545 patients whose records were scanned retrospectively in our study, 235 (43%) were female and 310 (57%) were male. Average age of patients was 70±14.2 years (20,100). Leading cause for receiving pacemaker was third degree atrioventricular block (178 patients, 32.6%).Other causes were bradycardia or asystole during procedures such as coronary angiography, catheterization etc. (101 patients, 18.5%), symptomatic sinus bradycardia (70 patients, 12.8%), pacemaker end of life (During procedure, 65 patients, 11.9%). Temporary pacemaker implantation due to drugs, hyperpotasemia and both was 6.2% (34 patients), 3.6% (20 patients) and 1.1% (6 patients) respectively. Eight patients used drugs for committing suicide. While the top responsible drugs for pacemaker implantation were digoxin, beta blockers and calcium channel blockers, only one patient was using a noncardiac drug (oxcarbamazepin). Half of the patients had coronary artery disease (276 patients, 51%). 101 patients (18.5%) received a temporary pacemaker due to block in the course of myocardial infarction. 85 patients died during their hospitalization (15.5%).
Conclusıon: Although causes for temporary pacemaker implantation has changed over time, myocardial infarction with block still remains fatal even a temporary pacemaker is inserted.
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.